Cargando…
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses
Development of effective vaccines to prevent influenza, particularly highly pathogenic avian influenza (HPAI) caused by influenza A virus (IAV) subtype H5N1, is a challenging goal. In this study, we designed and constructed two recombinant influenza vaccine candidates by fusing hemagglutinin 1 (HA1)...
Autores principales: | Du, Lanying, Leung, Virtual Ho-Chuen, Zhang, Xiujuan, Zhou, Jie, Chen, Min, He, Wu, Zhang, Hai-Ying, Chan, Chris C. S., Poon, Vincent Kwok-Man, Zhao, Guangyu, Sun, Shihui, Cai, Lifeng, Zhou, Yusen, Zheng, Bo-Jian, Jiang, Shibo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029370/ https://www.ncbi.nlm.nih.gov/pubmed/21304591 http://dx.doi.org/10.1371/journal.pone.0016555 |
Ejemplares similares
-
A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection
por: Du, Lanying, et al.
Publicado: (2013) -
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
por: Zhao, Guangyu, et al.
Publicado: (2010) -
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
por: Zhao, Guangyu, et al.
Publicado: (2010) -
Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam
por: Le, Thanh Hoa, et al.
Publicado: (2014) -
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)